Satoshi Washino

838 total citations · 1 hit paper
47 papers, 592 citations indexed

About

Satoshi Washino is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, Satoshi Washino has authored 47 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 11 papers in Rheumatology. Recurrent topics in Satoshi Washino's work include Prostate Cancer Diagnosis and Treatment (14 papers), Prostate Cancer Treatment and Research (14 papers) and Renal cell carcinoma treatment (6 papers). Satoshi Washino is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (14 papers), Prostate Cancer Treatment and Research (14 papers) and Renal cell carcinoma treatment (6 papers). Satoshi Washino collaborates with scholars based in Japan and United States. Satoshi Washino's co-authors include Tomoaki Miyagawa, Yutaka Kobayashi, Masaru Hirai, Kimitoshi Saito, Tsuzumi Konishi, Tomohisa Okochi, Keiko Hosohata, Y Arai, Hitoshi Ando and Tatsuo Morita and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and European Journal of Pharmacology.

In The Last Decade

Satoshi Washino

40 papers receiving 585 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combination of prostate imaging reporting and data system ( PI ‐ RADS ) score and prostate‐specific antigen ( PSA ) density predicts biopsy outcome in prostate biopsy naïve patients

2016 248 citations Satoshi Washino, Tomohisa Okochi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Satoshi Washino Japan	12	397	192	117	77	74	47	592
Keng Lim Ng Australia	13	337 0.8×	65 0.3×	90 0.8×	59 0.8×	214 2.9×	32	540
Chad A. Reichard United States	15	493 1.2×	79 0.4×	114 1.0×	93 1.2×	112 1.5×	42	707
Hirotaka Asakura Japan	13	282 0.7×	86 0.4×	130 1.1×	95 1.2×	108 1.5×	48	558
Nicholas J. Fitzsimons United States	9	337 0.8×	63 0.3×	60 0.5×	84 1.1×	38 0.5×	10	406
Claude Darte United States	9	219 0.6×	51 0.3×	57 0.5×	111 1.4×	115 1.6×	15	517
Yi Shao China	13	413 1.0×	100 0.5×	52 0.4×	35 0.5×	133 1.8×	39	630
Hulin Li China	12	380 1.0×	112 0.6×	75 0.6×	71 0.9×	116 1.6×	36	610
Adriana Reyes United States	15	630 1.6×	334 1.7×	288 2.5×	219 2.8×	126 1.7×	26	993
Carl A. Olsson United States	8	374 0.9×	55 0.3×	190 1.6×	109 1.4×	175 2.4×	8	616
Jean-Baptiste Lattouf Canada	19	732 1.8×	111 0.6×	499 4.3×	245 3.2×	338 4.6×	29	1.2k

Countries citing papers authored by Satoshi Washino

Since Specialization

Citations

This map shows the geographic impact of Satoshi Washino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Washino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Washino more than expected).

Fields of papers citing papers by Satoshi Washino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Washino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Washino. The network helps show where Satoshi Washino may publish in the future.

Co-authorship network of co-authors of Satoshi Washino

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Washino. A scholar is included among the top collaborators of Satoshi Washino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Washino. Satoshi Washino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kawase, Makoto, Satoshi Washino, Takeshi Yamasaki, et al.. (2025). Neoadjuvant Chemohormonal Therapy Versus Pelvic Lymphadenectomy on Biochemical Recurrence in Patients with High- or Very-High-Risk Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy. Diseases. 13(4). 92–92.

Kawase, Makoto, Satoshi Washino, Hajime Fukushima, et al.. (2025). Efficacy of Neoadjuvant Hormonal Therapy for High-Risk Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Study Using Propensity Score-Matched Analysis in Japan. Clinical Genitourinary Cancer. 23(3). 102346–102346.

Sano, Y., Masaharu Inoue, Satoshi Washino, et al.. (2025). Clinical outcomes of retreatment or discontinuation after interruption of nivolumab plus ipilimumab due to immune-related adverse events in metastatic renal cell carcinoma patients: A retrospective multicenter study. Urologic Oncology Seminars and Original Investigations. 44(2). 123.e1–123.e9.

Washino, Satoshi, et al.. (2024). A novel anterior approach toward robotic radical prostatectomy is associated with earlier continence recovery than the conventional approach. International Journal of Urology. 32(1). 80–87.

Washino, Satoshi, et al.. (2024). A novel anterior approach that involves Retzius space development between the umbilical ligaments is associated with a lower incidence of postoperative inguinal hernia in robotic radical prostatectomy. Prostate International. 12(1). 52–56. 2 indexed citations

Tanaka, Akira, Yukiko Fukuda, Satoru Takahashi, et al.. (2024). Cribriform Pattern Is a Predictive Factor of PSA Recurrence in Patients Receiving Radiotherapy After Prostatectomy. Cancer Diagnosis & Prognosis. 4(6). 715–721.

Nakayama, Takayuki, Hideki Takeshita, Satoshi Washino, et al.. (2024). Prognostic significance of inflammatory markers in patients with advanced renal cell carcinoma receiving nivolumab plus ipilimumab. International Journal of Clinical Oncology. 29(10). 1528–1537. 4 indexed citations

Washino, Satoshi, Makoto Kawase, Masaki Shimbo, et al.. (2024). Comparison of oncological outcomes between extended and no pelvic lymph node dissection in patients with high- or very high-risk prostate cancer: a multi-institutional study. Prostate International. 12(3). 160–166. 2 indexed citations

Inoue, Masaharu, Satoshi Washino, Suguru Shirotake, et al.. (2022). Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non‐clear cell renal cell carcinoma: Real‐world data from a Japanese multicenter retrospective study. International Journal of Urology. 30(9). 714–721. 9 indexed citations

10.

Oshima, Masashi, et al.. (2022). Retzius-sparing robotic prostatectomy is associated with higher positive surgical margin rate in anterior tumors, but not in posterior tumors, compared to conventional anterior robotic prostatectomy. Prostate International. 11(1). 13–19. 9 indexed citations

11.

Washino, Satoshi, et al.. (2021). Association between time to lithotripsy and stone-free rate in patients with ureteral stones undergoing shock wave lithotripsy. Urolithiasis. 49(4). 351–358.

12.

Washino, Satoshi, et al.. (2021). Calcium Channel Blockers Are Associated with Nocturia in Men Aged 40 Years or Older. Journal of Clinical Medicine. 10(8). 1603–1603. 4 indexed citations

13.

Washino, Satoshi, Lina Romero, Angela M. Ohm, et al.. (2019). Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination. Molecular Cancer Research. 17(10). 1985–1998. 16 indexed citations

14.

Washino, Satoshi, Keiko Hosohata, Masashi Oshima, et al.. (2019). A Novel Biomarker for Acute Kidney Injury, Vanin-1, for Obstructive Nephropathy: A Prospective Cohort Pilot Study. International Journal of Molecular Sciences. 20(4). 899–899. 22 indexed citations

15.

Washino, Satoshi, Shigeru Kobayashi, Tomohisa Okochi, et al.. (2018). Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study. BMC Urology. 18(1). 51–51. 15 indexed citations

16.

Saito, Kimitoshi, et al.. (2017). Transperineal ultrasound-guided prostate biopsy is safe even when patients are on combination antiplatelet and/or anticoagulation therapy. BMC Urology. 17(1). 53–53. 6 indexed citations

17.

Washino, Satoshi, Keiko Hosohata, Denan Jin, Shinji Takai, & Tomoaki Miyagawa. (2017). Early urinary biomarkers of renal tubular damage by a high‐salt intake independent of blood pressure in normotensive rats. Clinical and Experimental Pharmacology and Physiology. 45(3). 261–268. 18 indexed citations

18.

Ando, Hitoshi, Kazuhiko Nakano, Kentaro Ushijima, et al.. (2016). Influence of genetic polymorphisms of multidrug and toxin extrusion protein 1 on its mRNA expression in peripheral blood cells. Journal of Pharmacological Sciences. 131(2). 138–140. 1 indexed citations

19.

Saito, Kimitoshi, Satoshi Washino, Masaru Hirai, et al.. (2013). A CASE OF ISOLATED POLYARTERITIS NODOSA APPEARED IN BILATERAL EPIDIDYMIDES WITH ASYNCHRONOUS ONSET. The Japanese Journal of Urology. 104(1). 22–25. 1 indexed citations

20.

Washino, Satoshi, et al.. (2008). TWO CASES OF SQUAMOUS CELL CARCINOMA OF UPPER URINARY TRACT WITH HYPERCALCEMIA. The Japanese Journal of Urology. 99(6). 703–708. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact